Alzheimer's Drug Discovery Foundation co-founder discusses Kisunla

The Food and Drug Administration approved a new drug to help slow the progression of Alzheimer's Disease. Eli Lilly's Kisunla is the second drug, in just a few years, aimed at helping patients with early dementia. Dr. Howard Fillit, co-founder and chief science officer at the Alzheimer's Drug Discovery Foundation, joined FOX 5 on the Plus to discuss.

Top Videos